Author sees NVO undervalued after Oral Wegovy positive news and plans to accumulate shares.
NVO — LONG The author believes Novo Nordisk stock is undervalued on a P/E basis. The positive news about Oral Wegovy passing and reaching the market is providing traction. The author plans to continue accumulating shares over the next few months.
At even this price I still think it’s pretty undervalued given the P/E ratio, so I’m going to continue to accumulate more shares over the next coming months
This Reddit post, published January 06, 2026, features u/SelfMastery__ discussing NVO. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/SelfMastery__ · Tickers: NVO